ArticleNature communications2026
4D injection molding.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
Injection molding is a foundational manufacturing process for the large-scale production of plastic parts and is also applied to rubber, metal, ceramic, glass, wood, and composites. Regular injection molding focuses on minimizing warpage and ensuring dimensional uniformity and high repeatability, as non-uniform material shrinkage in complex mold cavities causes undesirable deformations. In contrast, we reverse this traditional paradigm by leveraging controlled solidification shrinkage to induce purposeful, programmable deformation. We propose 4D injection molding, utilizing localized thermal activation and selective in-mold bonding to create non-uniform temperature and pressure distributions in spatiotemporal dimensions during the molding cycle. This enables the generation of complex, customized geometries from a single mold. Integrated with predictive modeling and multi-objective response optimization, our approach transforms warpage from a defect into a design feature, yielding functional parts with tunable shapes and performance characteristics. This method supports rapid, scalable, and cost-efficient mass customization across various materials. By reimagining shrinkage not as a limitation but as a design opportunity, the method represents a transformative shift in manufacturing science, with promising applications in biomedical, aerospace, and responsive consumer products.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.